Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03254342 · ClinicalTrials.gov registry record
MRS and Medication Response: A Pilot Study
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT03254342: Clinical Trial study, sponsored by Stanford University.
NCT03254342 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03254342 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
We hope to demonstrate that magnetic resonance spectroscopy can detect brain concentration levels of paroxetine (Paxil) or citalopram (Celexa) or escitalopram (Lexapro) in depressed patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-08-06 |
| Est. Completion | 2020-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03254342
The ClinicalTrials.gov registry entry for NCT03254342 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03254342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03254342 about?
NCT03254342 is a clinical study titled "MRS and Medication Response: A Pilot Study". We hope to demonstrate that magnetic resonance spectroscopy can detect brain concentration levels of paroxetine (Paxil) or citalopram (Celexa) or escitalopram (Lexapro) in depressed patients.
What is the current status of trial NCT03254342?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2013-08-06. Estimated completion is 2020-08-31.
Who is sponsoring clinical trial NCT03254342?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.